TY - JOUR
T1 - Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation
AU - Sgueglia, Gregory Angelo
AU - Sestito, Alfonso
AU - Spinelli, Antonella
AU - Cioni, Beatrice
AU - Infusino, Fabio
AU - Papacci, Fabio
AU - Bellocci, Fulvio
AU - Meglio, Mario
AU - Crea, Filippo
AU - Lanza, Gaetano Antonio
PY - 2007/5
Y1 - 2007/5
N2 - Objective: To assess the long-term effect of spinal cord stimulation (SCS) in patients with refractory cardiac syndrome X (CSX). Methods: A prospective, controlled, long-term follow-up was performed of 19 patients with CSX with refractory angina who underwent SCS (SCS group, 5 men, mean (SD) age 60.9 (8.5) years); 9 comparable patients with CSX who refused SCS treatment (3 men, mean (SD) age 60.9 (8.8) years) constituted the control group. Clinical and functional status were assessed at the time of screening for SCS indication (basal evaluation) and at a median (range) follow-up of 36 (15-82) months. Results: The two groups at baseline did not show any difference in clinical characteristics and angina status. All indicators of angina status (angina episode frequency, duration and short-acting nitrate use) improved significantly at follow-up in the SCS group (p
AB - Objective: To assess the long-term effect of spinal cord stimulation (SCS) in patients with refractory cardiac syndrome X (CSX). Methods: A prospective, controlled, long-term follow-up was performed of 19 patients with CSX with refractory angina who underwent SCS (SCS group, 5 men, mean (SD) age 60.9 (8.5) years); 9 comparable patients with CSX who refused SCS treatment (3 men, mean (SD) age 60.9 (8.8) years) constituted the control group. Clinical and functional status were assessed at the time of screening for SCS indication (basal evaluation) and at a median (range) follow-up of 36 (15-82) months. Results: The two groups at baseline did not show any difference in clinical characteristics and angina status. All indicators of angina status (angina episode frequency, duration and short-acting nitrate use) improved significantly at follow-up in the SCS group (p
UR - http://www.scopus.com/inward/record.url?scp=34247884396&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34247884396&partnerID=8YFLogxK
U2 - 10.1136/hrt.2006.102194
DO - 10.1136/hrt.2006.102194
M3 - Article
C2 - 17237133
AN - SCOPUS:34247884396
VL - 93
SP - 591
EP - 597
JO - Heart
JF - Heart
SN - 1355-6037
IS - 5
ER -